| Model | Reference | Type of DR | DR effects on inflammatory or other brain pathology markers | DR effects on cognitive or motor functions | DR effects on imaging measures |
|---|---|---|---|---|---|
| Aging | |||||
| Rodents | Morgan et al., 1999; Lee et al., 2000 | 30–40% DR | ↓ Age-related increased of activation markers on microglia (e.g., MHCII) or astrocytes (e.g., GFAP); ↓ inflammatory genes | ||
| Kaur et al., 2008 | IF | ↓ Age-related changes in brain expression of NCAM, PSA-NCAM, and GFAP | |||
| Singh et al., 2012 | IF | ↓ Protein oxidative damage; ↑ markers of synaptic plasticity in the hippocampus | Ameliorates motor coordination, cognitive skills | ||
| Nonhuman primates | Qin et al., 2006 | 30% DR | ↓ Aβ deposition | ||
| Willette et al., 2010 | 30% DR | Attenuates the relation between IL-6 and brain volume loss | Attenuates the relation between IL-6 and brain volume loss | ||
| Willette et al., 2012 | 30% DR | Attenuates the negative correlation between homocysteine and global gray matter volume | Attenuates the negative correlation between homocysteine and global gray matter volume | ||
| Colman et al., 2009; Kastman et al., 2012; Sridharan et al., 2012; Sridharan et al., 2013 | 30% DR (University of Wisconsin study) | ↓ Age-related astrogliosis (↓ GFAP in hippocampus and entorhinal cortex) | Preserves motor performance | No effect on corpus callosum integrity; ↑ FA in several white matter regions; ↓ GM volume loss; ↓ brain iron accumulation | |
| Humans | Leclerc et al., 2020; Witte et al., 2009 | 25–30% DR | Ameliorates memory performance | ↓ C reactive protein and insulin levels | |
| Blumenthal et al., 2010; Smith et al., 2010 | DASH diet (Appel et al., 1997) and DR | Improves cognitive function | |||
| AD | |||||
| Rodents | Patel et al., 2005; Wang et al., 2005; Wu et al., 2008; Schafer et al., 2015 | 30–40% DR | ↓ Aβ and phospho-tau deposition; ↓ astrocyte activation | Improved performance in cognitive tests | |
| Halagappa et al., 2007; Brownlow et al., 2014 | Different DR regimens based on individual calorie consumption; 35–40% DR | No effects | Improved age-related behavioral impairments; rescued associative memory deficits | ||
| Humans | Horie et al., 2016 | DASH diet + DR 500 kcal/d or 25% DR | Improvement in cognitive functions | ||
| PD | |||||
| Rodents | Duan and Mattson, 1999 | IF | ↓ Damage to SN neurons | ↓ Motor deficits | |
| Maswood et al., 2004 | 30% DR | ↑ Levels of dopamine and dopamine metabolites in the striatal region | ↑ Locomotor activity | No differences in presynaptic dopaminergic activity in vivo | |
| Armentero et al., 2008 | IF | No effect on nigrostriatal degeneration | |||
| Griffioen et al., 2013 | IF | NA | Ameliorates autonomic function | NA | |
| Nonhuman primates | Maswood et al., 2004 | 30% DR | ↑ Levels of dopamine and dopamine metabolites in the striatal region | ↑ Locomotor activity | No differences in presynaptic dopaminergic activity in vivo |
| ALS | |||||
| Rodents | Pedersen and Mattson, 1999 | IF | Accelerates disease onset and shortens disease duration | ||
| Hamadeh et al., 2005 | 40% DR | Accelerates disease onset | |||
| MS | |||||
| Rodents | Esquifino et al., 2007 | 66% | Alters lymphocytes composition in lymphoid organs, ↓ IFN-γ production | Prevents EAE | |
| Piccio et al., 2008 | 40% DR | ↑ Corticosterone and adiponectin; ↓ leptin and IL-6 | Ameliorates EAE clinical course | ||
| Kafami et al., 2010 | IF | Ameliorates EAE clinical course and reduces incidence of disease | |||
| Cignarella et al., 2018 | IF | ↓ Th17 cells, ↑ T regulatory cells in small intestine lamina propria, altered gut microbiota | Ameliorates EAE clinical course and reduces incidence of disease | ||
| Jordan et al., 2019 | IF | ↓ Monocyte infiltration in the spinal cord, ↓ TNFα, IL-1β, CXCL2, and CXCL10 | Ameliorates EAE clinical course and reduces incidence of disease | ||
| Humans | Saadatnia et al., 2009 | Ramadan fasting | Well tolerated, no differences in relapse rate | ||
| Etemadifar et al., 2016 | Ramadan fasting | Improves physical health and mental health composites of QOL | |||
| Choi et al., 2016 | FMD + Mediterranean or ketogenic diet | Improves QOL | |||
| Fitzgerald et al., 2018 | 22% DR or IF | Improves mood | |||
| Cignarella et al., 2018 | IF | ↓ Leptin | |||
| Model | Reference | Type of DR | DR effects on inflammatory or other brain pathology markers | DR effects on cognitive or motor functions | DR effects on imaging measures |
|---|---|---|---|---|---|
| Rodents | 30–40% DR | ↓ Age-related increased of activation markers on microglia (e.g., MHCII) or astrocytes (e.g., GFAP); ↓ inflammatory genes | |||
| IF | ↓ Age-related changes in brain expression of NCAM, PSA-NCAM, and GFAP | ||||
| IF | ↓ Protein oxidative damage; ↑ markers of synaptic plasticity in the hippocampus | Ameliorates motor coordination, cognitive skills | |||
| Nonhuman primates | 30% DR | ↓ Aβ deposition | |||
| 30% DR | Attenuates the relation between IL-6 and brain volume loss | Attenuates the relation between IL-6 and brain volume loss | |||
| 30% DR | Attenuates the negative correlation between homocysteine and global gray matter volume | Attenuates the negative correlation between homocysteine and global gray matter volume | |||
| 30% DR (University of Wisconsin study) | ↓ Age-related astrogliosis (↓ GFAP in hippocampus and entorhinal cortex) | Preserves motor performance | No effect on corpus callosum integrity; ↑ FA in several white matter regions; ↓ GM volume loss; ↓ brain iron accumulation | ||
| Humans | 25–30% DR | Ameliorates memory performance | ↓ C reactive protein and insulin levels | ||
| DASH diet ( | Improves cognitive function | ||||
| Rodents | 30–40% DR | ↓ Aβ and phospho-tau deposition; ↓ astrocyte activation | Improved performance in cognitive tests | ||
| Different DR regimens based on individual calorie consumption; 35–40% DR | No effects | Improved age-related behavioral impairments; rescued associative memory deficits | |||
| Humans | DASH diet + DR 500 kcal/d or 25% DR | Improvement in cognitive functions | |||
| Rodents | IF | ↓ Damage to SN neurons | ↓ Motor deficits | ||
| 30% DR | ↑ Levels of dopamine and dopamine metabolites in the striatal region | ↑ Locomotor activity | No differences in presynaptic dopaminergic activity in vivo | ||
| IF | No effect on nigrostriatal degeneration | ||||
| IF | NA | Ameliorates autonomic function | NA | ||
| Nonhuman primates | 30% DR | ↑ Levels of dopamine and dopamine metabolites in the striatal region | ↑ Locomotor activity | No differences in presynaptic dopaminergic activity in vivo | |
| Rodents | IF | Accelerates disease onset and shortens disease duration | |||
| 40% DR | Accelerates disease onset | ||||
| Rodents | 66% | Alters lymphocytes composition in lymphoid organs, ↓ IFN-γ production | Prevents EAE | ||
| 40% DR | ↑ Corticosterone and adiponectin; ↓ leptin and IL-6 | Ameliorates EAE clinical course | |||
| IF | Ameliorates EAE clinical course and reduces incidence of disease | ||||
| IF | ↓ Th17 cells, ↑ T regulatory cells in small intestine lamina propria, altered gut microbiota | Ameliorates EAE clinical course and reduces incidence of disease | |||
| IF | ↓ Monocyte infiltration in the spinal cord, ↓ | Ameliorates EAE clinical course and reduces incidence of disease | |||
| Humans | Ramadan fasting | Well tolerated, no differences in relapse rate | |||
| Ramadan fasting | Improves physical health and mental health composites of QOL | ||||
| FMD + Mediterranean or ketogenic diet | Improves QOL | ||||
| 22% DR or IF | Improves mood | ||||
| IF | ↓ Leptin | ||||
Summary of the main studies on the effects of DR on aging and neurodegenerative and neuroinflammatory diseases. FA, fractional anisotropy. GM, gray matter; NA, not applicable; NCAM, neural cell adhesion molecule; PSA, polysialylated; QOL, quality of life; SN, substantia nigra.
As a benefit of your subscription, you can share temporary access to restricted articles.
Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.
Please sign in to your personal account to gift article access.
As a benefit of your subscription, you can share temporary access to restricted articles.
Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.
Gift articles remaining: --
Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.
Gift articles remaining: --
As a benefit of your subscription, you can share temporary access to restricted articles.
Each link will stop working after 30 days or 10 uses.
You have reached the limit of 10 links within a 30 day period.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.